Pacific Scientific Energetic Materials Company Signs MOU with Space Information Laboratories to Provide Plug-and-Play Autonomous Flight Safety System (AFSS)

- Results published in first paper from 18-month analysis of ongoing pivotal Phase 3 trial were generally consistent with overall efficacy and safety data reported in previously published 12-month analysis.

- Pivotal Phase 3 trial met all secondary endpoints for which there were a sufficient number of dengue cases. -

In the second paper, final 48-month results from a Phase 2 trial described long-term safety and demonstrated the durability of immune responses to Takeda’s dengue vaccine candidate. Results further support the two-dose schedule studied in pivotal Phase 3 trial.

With Doxy.me, healthcare providers can get a free, secure, GDPR and PHIPA-compliant telemedicine solution up and running in just minutes

SALT LAKE CITY-Thursday 19 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Doxy.me, a free, secure telemedicine solution, stands ready to meet increased demand for a simple, convenient way for healthcare providers to meet with their patients remotely, promising to improve the health care experience during this critical time.

Most telemedicine software products require a lengthy sales cycle, including training, legal review, and software or hardware to install. The process can take weeks to months to get up and running. Doxy.me was designed to be easy to install and simple to use; there are no downloads or apps to install and patients don't need to create accounts. The process is automated, so providers can start practicing telemedicine quickly, even within minutes. This approach means that Doxy.me is perfectly suited to hand ... Read more »